Navigation Links
Bocavirus infection may be associated with pneumonia in Thailand, especially in children

The newly identified human bocavirus was found in nearly 5 percent of pneumonia patients in rural Thailand, mostly in very young children. Researchers from the Centers for Disease Control and Prevention report their findings today at the International Conference on Emerging Infectious Diseases

"Our preliminary data suggests that human bocavirus may be associated with pneumonia in Thailand, especially among young children," says Alicia Fry, one of the researchers on the study.

Human bocavirus (HBoV) is a recently identified parvovirus that has been found in respiratory secretions of children with lower respiratory tract infections (LRTI). First reported in Sweden in September 2005, it is only the second member of the family Parvoviridae to be associated with human disease and the first to be linked with respiratory illness. Two additional studies in Australia and Japan have also identified HBoV in children with LRTI. However, whether the virus causes LRTI, the spectrum of clinical illness, and the epidemiology of HBoV infections still need to be defined. Fry cautions, "We still do not know if the virus actually causes respiratory tract infections and we hope to get closer to the answer with our final analysis."

The research was carried out through the Thailand International Emerging Infection Program (IEIP), a collaborative project between the Thailand Ministry of Health and the CDC that began in 2001. "The Thailand IEIP population-based surveillance for severe pneumonia patients of all ages is a unique opportunity to define the epidemiology of new viruses, "says Sonja Olsen, Acting Director of the IEIP and one of the researchers.

The researchers tested nasopharyngeal swab specimens collected from hospitalized pneumonia patients in rural Thailand between September 1, 2004 and August 31, 2005 for the presence of HBoV and compared them with specimens taken from a group of healthy volunteers. In preliminary analysis, 53 (4.5%) of
'"/>

Source:American Society for Microbiology


Page: 1 2

Related biology news :

1. Dysentery uses sword and shield to cause infection
2. Topical treatment shown to inhibit HIV and herpes simplex virus infection
3. Novel antiviral technology inhibits RSV infection in mice
4. Bacteria collection sheds light on urinary tract infections
5. Scientists decipher genome of fungus that can cause life-threatening infections
6. Yale researchers identify molecule for detecting parasitic infection in humans
7. Molecule that usually protects infection-fighting cells may cause plaque deposits inside arteries
8. Light therapy may combat fungal infections, new evidence suggests
9. Gladstone investigators discover how resting T cells avoid HIV infection
10. New strategies to reduce hospital-aquired infections
11. Virologists make major step towards understanding the process of HIV infection

Post Your Comments:
(Date:11/20/2009)...f flax shives, and generated from Brassica carina...h engulf fields in spring, can be used to produce ... carried out by Spanish and Dutch researchers and ...e Energy Reviews . , "These studies evaluate, fro...f bioethanol from two, as yet unexploited sources ...
(Date:11/20/2009)...enter (ERC) has been awarded a grant from the U.S....recovering and reusing the heat that would be gene...ocess in a carbon capture system. The goal of the ...nd sequestration, or storage (CCS), and thus limit...to the atmosphere by coal-fired power plants. , ...
(Date:11/19/2009)...ical with an unwieldy name: 4-hydroxybutyrate (4-H...date-rape drug. , Now, a team of Ohio and Michi... 4-HB is metabolized by the body. "This is new and...rofessor and chair of biological sciences at Michi...esearch team. "It may provide new clues on how to...
Breaking Biology News(10 mins):Flax and yellow flowers can produce bioethanol 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Researchers begin to decipher metabolism of sexual assault drug 2The ends of mRNAs may prevent the beginnings of cancer 9638 1The ends of mRNAs may prevent the beginnings of cancer 9638 2Disrupting a destructive duo 3A U of T Mississauga researchers inhibit cancer proteins 9634 1Disrupting a destructive duo 3A U of T Mississauga researchers inhibit cancer proteins 9634 2Nostrils Compete to Relay Key Fragrance 54963 1Nostrils Compete to Relay Key Fragrance 54963 2
...considered the one and only way biological traits ...sms. , Not anymore. , Increasingly, biologists ...ring the life of an organism can sometimes be pass... inheritance. An article forthcoming in the July i...er 100 well-documented cases of epigenetic inherit...
...Project, which involves the Overseas Development G... to encourage sustainable development schemes in d...on, mitigation and conservation benefits, as well ...years an innovative web-based system will be devel...mount of carbon, and other greenhouse gas emission...
...that is black, brittle and freeze-dried (just like...retty impressive feats. Designed by Northwestern U...luted water, easily separate hydrogen from other g...e effective catalyst than the one currently used t...ation might be a mouthful, but it is also a widely...
Other Biology News:100 reasons to change the way we think about genetics 2100 reasons to change the way we think about genetics 3Carbon measuring system to help mitigate climate change 2Carbon measuring system to help mitigate climate change 3One sponge-like material, three different applications 2One sponge-like material, three different applications 3
(Date:11/20/2009)...TOLEDO recently announced that a free webinar, &ld...At-Line Particle Characterization”, will be ...he application of in situ particle characterizatio...mize a series of roller compaction runs while vary...on forces. , (PRWEB) Nove...
(Date:11/19/2009)...swire-FirstCall/ -- Omeros Corporation (Nasdaq: O...for the third quarter ended September 30, 2009. Fo...s reported a net loss of $3.9 million, or $1.34 pe..., or $2.54 per share, for the same period in 2008.... Company reported a net loss of $15.5 million, or ...
(Date:11/19/2009)... Spherix Incorporated (Na...iabetes therapy, and a provider of technical and r... biotechnology and pharmaceutical companies, today... of Shareholders. ,, At the meeting, shareholde...d the following members to the Board of Directors:...
(Date:11/19/2009)...K surgeons and recognized refractive and cataract ...ade brought their fellow surgeons up-to-date on th..., cataract surgery, and ophthalmology in general a...almology (AAO) annual meeting in San Francisco, Ca...r, Dr. David Huang, MD, Dr. Randy Epstein, Dr. Wil...
Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9
... 12 /PRNewswire-FirstCall/ - Neptune Technologies ...V.NTB), "Neptune" today,announced its results for ...e,s Highlights:, - First Quarter ended August 3...5,000 compared to $1,552,000, for the fir...., - EBITDA increased by 10% to $332,000 co...
... on Global List for Fifth Consecutive Year, CAMBR... GENZ ) announced today that scientists have agai...king the reputations of biotechnology and,pharmace...nearly 500,companies. Over the past five years Gen...ll biotechnology and pharmaceutical companies. Gen...
...fforts to Expand Market and Prepare for Zingo Laun...y Donahue Promoted To Senior Vice President, Marke...To Vice President, Marketing - - Addit...s to be Presented at Investor Briefing Today at 12... -, SOUTH SAN FRANCISCO, Calif., Oct. 12 Anesiva...
Other Biology Technology:Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update 2Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update 3Genzyme Recognized by Scientists as a Top Employer 2Genzyme Recognized by Scientists as a Top Employer 3Genzyme Recognized by Scientists as a Top Employer 4Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 2Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 3Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 4Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 5Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 6Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 7
Rat Anti-Human MFRP Monoclonal Antibody, Unconjugated, Clone 291218 from R&D Systems
Rabbit Anti-HOXD3 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Mouse Anti-Human Complement Component C5a Monoclonal Antibody, Unconjugated, Clone 295003 from R&D Systems
Goat Anti-Human CXCL14 / BRAK Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: